66 filings
Page 2 of 4
8-K
y8rxxndk
2 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
v0umae45ssxdj1dr4b9
14 Jun 22
Submission of Matters to a Vote of Security Holders
4:59pm
8-K
g5vppbmq8jq dk0
25 Mar 22
Departure of Directors or Certain Officers
5:23pm
8-K
u32p j4ohdiu0
15 Feb 22
ImmunityBio Completes Acquisition of Athenex’s Interest in Dunkirk, New York Advanced
9:00am
8-K
bec 1q85ij3oo5
12 Jan 22
Entry into a Material Definitive Agreement
8:35am
8-K
wlqh7sjpf1m1x1r gobe
20 Dec 21
Immunitybio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of Covid
9:07am
8-K
w5e4bw9a0c
27 Sep 21
Entry into a Material Definitive Agreement
8:46am
8-K
82elssuicql
13 Sep 21
Results of Operations and Financial Condition
8:37am
8-K
zlxdg4tdnbr
13 Aug 21
Departure of Directors or Certain Officers
4:16pm
8-K
7kt yiq36
15 Jun 21
Submission of Matters to a Vote of Security Holders
7:11am
8-K
hm88m5s3baabe06oqf3
11 Jun 21
Results of Operations and Financial Condition
5:18pm
8-K
690xy846
4 Jun 21
Regulation FD Disclosure
8:30am
8-K
tme zwqwn
28 May 21
Entry into a Material Definitive Agreement
4:08pm
8-K
amz6y3j
3 May 21
Entry into a Material Definitive Agreement
6:06am
8-K/A
npganmnwma391rsx07d7
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K
p6l ntm84dzdq06v5
1 Apr 21
ImmunityBio Appoints Dr. Linda Maxwell and CEO Richard Adcock to Board of Directors
9:15am
8-K
r623kmq5b5a0
17 Mar 21
Regulation FD Disclosure
5:24pm
8-K
v4an7ew
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
8-K
6o4eos
25 Feb 21
Other Events
5:15pm
8-K
54wqn5t
24 Feb 21
ImmunityBio Appoints John Brennan and Wesley Clark to Board of Directors
4:59pm